文献速递细菌感染、耐药与抗菌药物医院感染防控

经肺内免疫诱导持久有效的抗金黄色葡萄球菌肺炎肺部免疫

Intrapulmonary Vaccination Induces Long-lasting and Effective Pulmonary Immunity Against Staphylococcus aureus Pneumonia.
PubMed 文献 · J Infect Dis · 2021-01-01

该研究在呼吸道小鼠模型中使用亚单位疫苗接种,评估经肺内免疫对金黄色葡萄球菌肺部感染的免疫应答和保护效果。与经鼻免疫小鼠相比,经肺内免疫小鼠肺部细菌定植和致死率更低,肺部炎症减轻,保护与肺部抗体和驻留记忆T细胞增加相关,且至少持续6个月。结论提示经肺内免疫可作为开发金黄色葡萄球菌肺炎疫苗的策略。

要点

  • 经肺内免疫较经鼻免疫降低小鼠肺部细菌定植和致死率。
  • 保护作用与肺部抗体及驻留记忆T细胞增加相关。
  • 经肺内免疫提供至少6个月的持久肺部保护。

核心结论

  • 经肺内免疫使疫苗到达深肺,对诱导针对金黄色葡萄球菌的有效且持久肺部免疫起重要作用。
  • 经肺内免疫可作为开发金黄色葡萄球菌肺炎疫苗的策略。

研究设计与样本

  • 研究在呼吸道小鼠模型中使用亚单位疫苗评估经肺内免疫对金黄色葡萄球菌肺部感染免疫应答和保护效果。

主要发现

  • 与经鼻免疫小鼠相比,经肺内免疫小鼠肺部细菌定植水平和致死率更低。
  • 经肺内免疫小鼠肺部炎症减轻,促炎细胞因子减少,白细胞介素-10和抗菌肽水平增加。
  • 最佳保护与肺部抗体和驻留记忆T细胞增加相关。
  • 经肺内免疫提供至少6个月的持久肺部保护,肺部持续存在细胞和体液免疫。

临床怎么用

  • 经肺内免疫策略可能用于开发针对金黄色葡萄球菌肺炎的疫苗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Staphylococcus aureus causes community- and hospital-acquired pneumonia linked to a high mortality rate. The emergence and rapid transmission of multidrug-resistant S. aureus strains has become a serious health concern, highlighting the challenges associated with the development of a vaccine to combat S. aureus pneumonia. METHODS: This study evaluated the effects of intrapulmonary immunization on the immune response and protection against S. aureus lung infection in a respiratory mouse model using a subunit vaccine. RESULTS: Compared with the intranasal immunized mice, the intrapulmonarily immunized mice had lower levels of pulmonary bacterial colonization and lethality, accompanied by alleviated lung inflammation with reduced proinflammatory cytokines and increased levels of interleukin-10 and antimicrobial peptide following intrapulmonary challenge. Optimal protection was associated with increased pulmonary antibodies and resident memory T cells. Moreover, intrapulmonary immunization provided long-lasting pulmonary protection for at least 6 months, with persistent cellular and humoral immunity in the lungs. CONCLUSIONS: Vaccine reaching the deep lung by intrapulmonary immunization plays a significant role in the induction of efficacious and long-lasting immunity against S. aureus in the lung parenchyma. Hence, intrapulmonary immunization can be a strategy for the development of a vaccine against S. aureus pneumonia.Immunization through the intrapulmonary route with a subunit of S. aureus vaccine elicited tissue resident memory T cells and antigen-specific antibodies in the lungs, and provided optimal and long-term protection against S. aureus pneumonia.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Fan X, Li N, Xu M, et al. Intrapulmonary Vaccination Induces Long-lasting and Effective Pulmonary Immunity Against Staphylococcus aureus Pneumonia. J Infect Dis. 2021. PMID: 33417695. doi:10.1093/infdis/jiab012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。